-+ 0.00%
-+ 0.00%
-+ 0.00%

Hansa Biopharma presents Idefirix PAES study at ASN Kidney Week

PUBT·10/20/2026 17:01:07
Listen to the news
Hansa Biopharma presents Idefirix PAES study at ASN Kidney Week
  • Hansa Biopharma’s Idefirix PAES study will feature in an oral presentation at ASN Kidney Week in Denver on October 23, 2026.
  • The High-Impact Clinical Trials session will cover the European study of 50 imlifidase crossmatch-positive deceased-donor kidney transplants.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansa Biopharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202610201300BITN____UKPR__EN_20261020-BIT-7065-0) on October 20, 2026, and is solely responsible for the information contained therein.